文献检索

查找使用阿拉丁产品的科研文献

检索与阿拉丁产品相关的同行评审论文、DOI、PubMed 编号、期刊、作者、CAS 号及研究领域。

科研影响力快照

与阿拉丁产品相关的已发表科研成果

在搜索之前,这些指标可帮助访客快速了解产品关联科研的规模与质量。

347,389+ SCI 论文 与阿拉丁产品引用相关
2,303,681.05 总影响因子 匹配文献记录中影响因子的总和
81.20 最高期刊影响因子 匹配期刊中的最高 IF
6.63 平均期刊影响因子 匹配文献的平均 IF

参考指标 指标基于阿拉丁文献引用数据库及期刊影响因子记录。文献关联仅供科研参考,请以原始文献为准。

产品列表

视图 列表 网格

显示第2449至2460个,产品总数347,389个

切换升序
Frontiers in Pharmacology · 2026 · IF 5.4

Acetylshikonin mitigates diet-induced MASLD by targeting PPARγ-mediated metabolic dysfunction

Ling Ou,Qian Du,Jiayang Liu,Haiyan Tai,Yinghan Chai,Xiaoqiong Tan,Bing Li,Lirong Tan,Ying Cao,Tingting Zhu

Introduction The liver, as the central metabolic hub of the body, is highly susceptible to diet-induced injury. The increasing prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) highlights the urgent need for effective clinical interventions. Currently, there are no specific therapeutics for MASLD, and dietary patterns are closely associated with its pathogenesis, making the exploration of natural bioactive compounds a promising strategy. Methods In this study, we identified acetylshikonin (AS), a component derived from traditional Chinese medicine (TCM), as a core bioactive agent targeting MASLD via a cross-screening strategy of MASLD-related TCM formulas. Male mouse models of MASLD were induced by a high-fat and high-cholesterol (HFHC) diet or carbon tetrachloride (CCl4) and treated with AS (600 mg/kg, gavage) for six consecutive weeks. In vitro experiments were conducted on Hepa1-6 and HCCLM3 hepatocytes stimulated with palmitic acid/oleic acid (PA/OA, 1:2). Integrated network pharmacology, molecular docking, and thermal shift assays were applied to explore the underlying mechanism. Results In vivo results showed that AS markedly attenuated hepatic steatosis (assessed by triglyceride and total cholesterol levels) and liver fibrosis (evaluated by collagen deposition). In vitro, AS suppressed intracellular lipid accumulation (validated by Oil Red O staining and lipid quantification) and inflammatory responses (assessed by pro-inflammatory cytokine expression) in the stimulated hepatocytes. Mechanistically, AS downregulated the transcriptional expression of key genes involved in lipid metabolism (Pparγ and Srebp1c), inflammation (Tnfα and Ccl2), and fibrosis (Col1a1 and Acta2) pathways. Integrated analyses confirmed peroxisome proliferator-activated receptor γ (PPARγ) as the core direct target of AS. Western blotting demonstrated that AS reduced PPARγ protein expression, and its lipid-lowering effect was synergistically enhanced when combined with the PPARγ antagonist GW9662. Discussion This is the first study to definitively confirm that AS exerts therapeutic effects on diet-induced MASLD by targeting the PPARγ signaling pathway, thereby reducing hepatic lipid deposition, alleviating inflammation, and ameliorating liver fibrosis progression. Our findings provide novel experimental evidence supporting the use of natural products in MASLD treatment and lay a theoretical foundation for the application of AS in the health management of diet-related liver diseases.

CAS / MDL: 112-80-1
✓ 已验证 产品关联 DOI PubMed 高影响因子
查看原文 查看 PubMed
JOURNAL OF HAZARDOUS MATERIALS · 2026 · IF 10.6

Silkworm excrement–immobilized bacteria for synergistic remediation of phthalate esters in agricultural soil

Yong-Hong Chen,Huan Du,Ying-Xi Liu,Ke Xu,Jin-Cheng Ye,Bai-Lin Liu,Nai-Xian Feng,Lei Xiang,Yan-Wen Li,Quan-Ying Cai,Ce-Hui Mo,Hai-Ming Zhao

The widespread contamination of agricultural soils by phthalate esters (PAEs) poses serious risks to ecosystem and human health. While microbial remediation is a promising solution, the poor survival and performance of free degrading bacteria in complex soil environments limit its practical application. To address this challenge, we develop a novel immobilized inoculant by leveraging silkworm excrement (SE), an agricultural by-product, as a carrier for the efficient PAE-degrader Pseudomonas aeruginosa PS1. This microbe-immobilized silkworm excrement (MSE) was thoroughly characterized and validated by pot experiments. The results showed that MSE treatment significantly reduced PAEs in both soil and choysum ( Brassica parachinensis L.), with PAEs detected little in shoots (edible parts), significantly outperforming the treatments of free bacteria or SE alone. The enhanced remediation was linked to MSE-induced improvements in soil health, including increased pH, organic matter, and ammonium nitrogen. Crucially, high-throughput sequencing revealed that MSE application selectively enriched key PAE-degrading bacterial phyla, particularly Proteobacteria and Bacteroidetes, thereby reshaping the soil microbiome into a more effective remediation consortium. This study presents a sustainable and efficient bioaugmentation strategy for transforming a waste product into a functional inoculant, offering a viable solution for the in-situ remediation of PAE-contaminated soils.

CAS / MDL: 117-81-7 84-74-2
✓ 已验证 产品关联 DOI 高影响因子
查看原文 查看 PubMed
BRAIN RESEARCH BULLETIN · 2026 · IF 4.5

SERPINE1 Drives Neuropathic Pain in a Resiniferatoxin-Induced Model via AKT-Mediated Neuronal Apoptosis

Dan Wang,Liran Xu,Yangang Sun,Jingyu Yue,Liangping Li

Postherpetic neuralgia (PHN) is a persistent neuropathic pain condition resulting from varicella-zoster virus reactivation, yet remains inadequately treated. Here, we elucidate a pathogenic function of Serpin Family E Member 1 (SERPINE1) in neuropathic pain using a resiniferatoxin (RTX)-induced neuropathic pain to simulate PHN. RTX administration triggered sustained mechanical allodynia and thermal hyposensitivity, accompanied by damage in the dorsal root ganglion (DRG) and sciatic nerve. Transcriptomic analysis identified SERPINE1 as a prominently upregulated gene in DRG following RTX challenge. Pharmacological inhibition of SERPINE1 with TM5441 alleviated pain-related behaviors in a dose-dependent manner, restored vanilloid 1 (TRPV1)-positive neuronal populations, and mitigated ultrastructural nerve pathology. Mechanistically, SERPINE1 suppression attenuated neuronal apoptosis (lowered caspase‑3) in the DRG. This anti‑apoptotic effect was associated with inhibition of the AKT pathway, evidenced by decreased AKT phosphorylation in both DRG tissues from RTX‑treated rats and RTX‑stimulated SH‑SY5Y cells. Our findings demonstrate that SERPINE1 drives neuropathic pain in the RTX model and highlight its pharmacological inhibition as a promising therapeutic strategy.

CAS / MDL: 28718-90-3
✓ 已验证 产品关联 DOI PubMed 高影响因子
查看原文 查看 PubMed
Food Packaging and Shelf Life · 2026 · IF 10.8

pH-responsive polyphenol–polyester composite films for active food packaging

Xin Hu,Zhen Zhang,Chen geng,Peijie Hou,Jun Wang,Yang Li,Lifang Zhang

Food spoilage driven by oxidative stress and microbial contamination remains a major challenge in minimally processed fruits, while the development of flexible biodegradable packaging systems with regulated and responsive bioactivity remains limited. In this study, a flexible bio-based active film was fabricated by incorporating gallic acid (GA) into a biodegradable poly( L -lactide)-b-poly(trimethylene carbonate) (PLLA-b-PTMC, PLT) matrix. Intermolecular hydrogen bonding between GA and PLT induced microstructural reorganization and altered chain mobility, enabling biphasic, diffusion-controlled GA release with pH-dependent behavior. The composite films exhibited reactive oxygen species scavenging activity, dose-dependent antibacterial performance against Escherichia coli and Staphylococcus aureus, and maintained cytocompatibility at effective GA loadings. Application in a fresh-fruit preservation model demonstrated delayed browning and moderated quality deterioration during storage. These findings indicate that regulating polymer–polyphenol interactions can align release behavior with storage-induced environmental changes, contributing to oxidative and microbial spoilage control in minimally processed fruits.

CAS / MDL: 149-91-7
✓ 已验证 产品关联 DOI 高影响因子
查看原文 查看 PubMed
Asian Journal of Pharmaceutical Sciences · 2026 · IF 12.6

MMP-9-responsive contact lens facilitating disease-adaptive and safer dexamethasone delivery for corneal neovascularization therapy

Chenxiao Chu,Xi Chen,Yaxin Deng,Jie Zhang,Xiaoshuang Bi,Yunfeng Ma,Mingli Wei,Jiansong Zhao,Haibing He,Jingxin Gou,Tian Yin,Xing Tang,Li Yang,Yu Zhang

Corneal neovascularization (CNV), an inflammation-driven pathological process responsible for irreversible vision loss, remains an urgent unmet challenge in ophthalmic medicine. Current interventions—ranging from surgery to topical steroids—fail to prevent recurrence or evade severe side effects like intraocular hypertension and even corneal ulceration. Here, we introduce CL-Peptide-Dex, a transformative contact lens (CL) engineered for matrix metalloproteinase-9 (MMP-9)-responsive dexamethasone (Dex) release, to resolve this decades-long challenge. By grafting dexamethasone on the lens surface via an MMP-9-cleavable peptide linker (GPLGLAGC), CL-Peptide-Dex achieves disease-adaptive drug delivery: rapid release during acute inflammation and sustained release throughout CNV progression. Unlike conventional drug-eluting systems, this surface-grafting strategy eliminates burst release while preserving lens transparency and oxygen permeability. In the rabbit corneal neovascularization model, a single administration of CL-Peptide-Dex could maintain a stable Dex level for 7 days, suppressed VEGF by 77.5%, and reduced neovascular area by 79.5%. Critically, CL-Peptide-Dex avoided intraocular pressure spikes and exhibited good corneal biocompatibility and compliance, enabling safe extended wear. By integrating MMP-9-responsive precision delivery with patient-friendly design, CL-Peptide-Dex represents a significant advance in precision ophthalmology.

✓ 已验证 产品关联 DOI PubMed 高影响因子
查看原文 查看 PubMed
BIORESOURCE TECHNOLOGY · 2026 · IF 8.2

Semi-rational design of psychrophilic cellobiose 2-epimerase for improved substrate affinity and enhanced low-temperature epimerization activity

Hu Xu,Niannian Lv,Yongqin Liu

Psychrophilic cellobiose 2-epimerase (CE) is a promising biocatalyst for cold-process dairy manufacturing, yet its industrial application is hampered by the inherent trade-off between low-temperature activity and substrate affinity. To overcome this limitation, a semi-rational design strategy was implemented on a psychrophilic CE (psyCE). A GFP-based fluorescence assay was developed to normalize mutant expression, enabling precise identification of activity improvements. Structure analysis pinpointed six key residues for targeted mutagenesis, and a saturation mutagenesis library was constructed accordingly. Screening of the library yielded a robust double mutant (FR) with superior kinetics. The FR variant exhibited a record-breaking catalytic turnover (245.7 s −1 vs. 219.9 s −1 ) and an improved substrate affinity (208.9 mM vs. 261.9 mM), resulting in a 40% increase in overall catalytic efficiency. In a practical biocatalysis trial at 8 °C, FR achieved a 21% epilactose yield within 3 h, outperforming the wild type (20% within 4 h). Molecular dynamics simulations revealed the structural basis of this enhancement by showing the FR mutant evolves an enlarged binding pocket, while simultaneously establishing a strengthened hydrogen-bond network. This study not only provides a highly efficient cold-active biocatalyst but also establishes a screening platform for engineering psychrophilic enzymes.

CAS / MDL: 20869-27-6
✓ 已验证 产品关联 DOI PubMed 高影响因子
查看原文 查看 PubMed
Nanomedicine-Nanotechnology Biology and Medicine · 2026 · IF 4.3

Nebulized delivery of multi-modular stem cell-derived exosomes for the treatment of pulmonary fibrosis

Xiaoyu Gao,Chunbin Sun,Yang Yang,Luping Li,Shuang Sha,Shanglin Cai,Liang Li,Zhongci Hang,Lei Wang,Cencan Xing,Hongwu Du

Pulmonary fibrosis (PF) is a terminal pathological manifestation of a group of lung diseases characterized by fibroblast proliferation, excessive extracellular matrix deposition, inflammatory damage, and structural destruction of lung tissue. The lung damage caused by PF is typically irreversible. Current medications and therapies can slow disease progression but fail to fully repair the damaged lung tissue. In this study, we developed a composite nanoparticle system from PNP@Exo using Poly(lactic-co-glycolic) acid (PLGA) as a carrier, which is capable of co-delivering the anti-fibrotic drug nintedanib and coated with polydopamine for adhering human umbilical cord mesenchymal stem cell-derived exosomes (hUC-MSCs-Exo) to synergistically harness their therapeutic effects. In vitro experiments demonstrated that the composite drug-loaded nanoparticles PNP@Exo significantly reduced the expression of inflammatory factors, COL I, and COL-III in bleomycin (BLM) induced A549 cells. Furthermore, administration of PNP@Exo into BLM-induced PF mice via nebulization significantly inhibited the production of extracellular matrix components and improved lung function without inducing systemic toxicity. Additionally, PNP@Exo inhibited the ferroptosis process in both PF cells and mice models. In conclusion, the composite drug-loaded nanoparticles synthesized in this study demonstrated a significant therapeutic efficacy in both PF cells and animal models, providing a novel strategy for the treatment of pulmonary fibrosis.

CAS / MDL: 51-61-6
✓ 已验证 产品关联 DOI PubMed 高影响因子
查看原文 查看 PubMed
JOURNAL OF INHERITED METABOLIC DISEASE · 2026 ·Vol. 49 ·期 2 ·e70168 · IF 3.8

Signal Peptide Engineering and Codon Optimization to Enhance α‐Gal A Activity for rAAV Gene Therapy of Fabry Disease

Siwu He,Li Yang,Ke Wan,Zhaoyue Zheng,Mi Leng,Chunmei Gan,Yu Liu,Lin Xiao,Jingya Ye,Zhian Chen,Jiao Zhou,C Alexander Valencia,Aliah Abuammah,Hoi Yee Chow,Biao Dong,Yucheng Chen

Fabry disease is an X‐linked lysosomal storage disorder caused by mutations in the GLA gene, leading to deficient α‐galactosidase A (α‐Gal A) activity and pathological accumulation of globotriaosylceramide (Gb3) and globotriaosylsphingosine (Lyso‐Gb3) in various organs. To enhance α‐Gal A expression and secretion for recombinant adeno‐associated viral (rAAV) gene therapy, the signal peptide was engineered in HepG2 cells. Among 22 heterogeneous signal peptides, sp21 was identified and validated for this purpose. The enzyme activity of GLA with sp21 in conditioned media was 2.3 times higher than that with the wild‐type signal peptide. Furthermore, the human GLA gene was codon optimized (hGLAco), aiming to achieve increased hepatic expression and prevent gene silencing. The secreted α‐Gal A activity of hGLAco increased approximately 4‐fold in vitro. Finally, the hGLAco transgene with sp21 driven by a liver‐specific promoter was packaged in rAAV8 vectors and injected into Fabry mice. Compared with the wild‐type cDNA, the engineered GLA gene resulted in a 6.9‐fold increase in secreted α‐Gal A activity in Fabry mice, and toxic Lyso‐Gb3 accumulation in plasma and key tissues was effectively cleared. These findings demonstrate a promising strategy to develop a more efficient rAAV gene therapy for Fabry disease.

CAS / MDL: 3672-15-9
✓ 已验证 产品关联 DOI PubMed 高影响因子
查看原文 查看 PubMed
JOURNAL OF NANOBIOTECHNOLOGY · 2026 · IF 15

Cell membranes-encapsulated gadolinium-doped carbon dots for the efficient photothermal and immunotherapeutic synergistic treatment of hepatocellular carcinoma

Wenhui Dong,Yingying Wei,Chenyue Cao,Hongkai Mu,Shizhao Zhou,Yueyong Xiao,Yongzhen Yang,Lin Chen,Shiping Yu

Hepatocellular carcinoma (HCC), a predominant subtype of liver cancer, is witnessing a rising global incidence and urgently demands the development of innovative nanoplatforms that integrate precise therapeutic and immune regulatory functions. To address the limitations of conventional monotherapies, which often suffer from inadequate tumor targeting, insufficient efficacy, and limited immune activation, this study employs a "biomimetic targeting-synergy therapy" approach. We have engineered a composite system consisting of gadolinium-doped carbon dots (Gd-CDs) enveloped with hepatocellular carcinoma cell membranes (HCM), thereby imparting homologous targeting capabilities and immune activation properties. This Gd-CDs@HCM system facilitates photothermal immunotherapy, guided by bimodal fluorescence (FL) and magnetic resonance (MR) imaging. Upon laser irradiation, Gd-CDs@HCM can induce immunogenic cell death (ICD) in tumor cells. The tumor-associated antigens (TAAs) and damage-associated molecular patterns (DAMPs) released during ICD collaboratively enhance systemic anti-tumor immunity in conjunction with HCM, achieving a primary tumor ablation rate of 84.9% and inhibiting tumor progression. Consequently, this research offers an innovative strategy for real-time monitoring and precise synergistic treatment of HCC by utilizing FL/MR bimodal imaging and integrating bionic targeting, localized thermal ablation, and immune activation functions.

CAS / MDL: 3599-32-4
✓ 已验证 产品关联 DOI PubMed 高影响因子
查看原文 查看 PubMed
SEPARATION AND PURIFICATION TECHNOLOGY · 2026 · IF 9.1

Synergistic Cu/Ag dual-sites in MOF-253 for high-efficiency carbonylative cyclization of CO2 under ambient conditions

Chao-Ying Gao,Yang Li,Wenbo Wang,Chenyu Liu,Jinghai Liu,Yang Yang

Developing heterogeneous catalysts capable of activating inert CO 2 under mild conditions remains a central challenge in sustainable chemistry. Herein, we report the rational design of a robust bimetallic platform, MOF-253-0.5(Cu/Ag), constructed by post-synthetic incorporation of synergistic Cu(II) and Ag(I) sites within the 2,2′-bipyridine pockets of the MOF-253 framework. The catalyst exhibits high turnover frequencies (TOF) of 260 h −1 under ambient conditions, ranking among the highest reports. It also maintains robust stability over 5 cycles, achieving a cumulative turnover number (TON) of 999.2. Even under diluted CO 2 conditions mimicking industrial flue gas, its catalytical activity remains largely unaffected. 1 H NMR mechanistic analysis was used to monitor the reaction processes. Comparative experiments with monometallic and pristine MOF confirm the superior performance of the bimetallic system, attributed to Cu/Ag synergy that activates both the C≡C bond and CO 2 . Furthermore, comprehensive density functional theory (DFT) calculations provided clear insights into the energetics and elementary steps of the catalytic cycles. This work highlights the power of site-isolated bimetallic MOFs in CO 2 chemical fixation.

✓ 已验证 DOI 高影响因子
查看原文 查看 PubMed
Nano Today · 2026 · IF 10.7

Deep tumor penetration of supramolecular Fmoc-Glyco/ Fmoc-diphenylalanine-DOX drug loaded nanorods for targeted chemotherapy

Yan Zhang,Lingxin Peng,Baotong Ye,Guodong Lu,Sichen Li,Jingjing Zhou,Mihail Barboiu,Jinghua Chen

Nanoparticles (NPs) have been extensively investigated in modern cancer chemotherapy for their advantages in targeted drug delivery, enhanced efficacy and reduced toxicity. However, clinical evidence continues to indicate modest therapeutic efficacy of these nanomedicines, largely attributed to insufficient drug accumulation and poor tissue penetration in tumors. In the current study, we discovered that synergetic and precise control over nanoparticle shape and surface functionalization improves tumor penetration and enhances chemotherapy outcomes. Specifically, supramolecular nanospheres/nanorods self-assembled from scaffolding Fmoc-FF, hepatocyte targeting Fmoc-monosaccharides and the anti-tumor drug doxorubicin (DOX) have been associated via the synergetic control of their nanostructured morphologies and the surface presentation of bioactive signals. These pH-sensitive self-assembled nanoparticles enable controlled nanostructure shape and multivalent carbohydrate-functionalized surfaces, allowing activation in the acidic tumor microenvironment for triggered drug release. In vitro experiments demonstrated that the galactose-modified nanorod FGal 1–2 , measuring approximately 250 nm in length and of 25 nm in diameter, displayed the highest toxicity towards HepG2 cells and significantly enhanced cellular uptake. Additionally, nanorod FGal 1–2 demonstrated the deepest penetration (> 80 μm) in a 3D tumor spheroid model, surpassing the nanosphere FGal 1–1 and longer nanorod FGal 1–3 . Moreover, in vivo animal studies further revealed higher tumor accumulation of nanorod FGal 1–2 compared to the corresponding nanosphere, along with the strongest tumor inhibition, markedly reduced cardiotoxicity of DOX, and an 85% reduction in tumor volume. This work offers new insights into the design of nanoparticles with functional/morphological effects in their properties for advanced anti-tumor drug delivery.

CAS / MDL: 109-63-7 1122-58-3
✓ 已验证 产品关联 DOI 高影响因子
查看原文 查看 PubMed
JOURNAL OF CATALYSIS · 2026 · IF 6

Engineered atomic Pd sites on a supermolecule nanosheet for efficient hydrogen peroxide photosynthesis

Hao Niu,Jiaqi Song,Lixia Yang,Liangjiu Bai,Kun Yin,Donglei Wei,Hou Chen,Huawei Yang

Solar-driven hydrogen peroxide (H 2 O 2 ) synthesis from water and oxygen stands as a sustainable and viable strategy, yet its progress remains constrained by the lack of high-performance photocatalysts. Here we report a Pd atomic site on tetrakis (4-carboxyphenyl) porphyrin supramolecular nanosheet catalyst for photocatalytic H 2 O 2 production. The optimized catalyst achieves an exceptional H 2 O 2 yield rate of 608 μmol g −1  h −1 under visible light. A combination of experimental investigations and theoretical simulations verifies that the H 2 O 2 generation proceeds via a dual-pathway mechanism, encompassing both the oxygen reduction reaction (ORR) and the water oxidation reaction (WOR). The Pd atomic sites not only enhance visible-light absorption and facilitate charge transport, but also serve as efficient electron traps that significantly lower the energy barriers for the formation of key intermediates (*OOH for the ORR pathway and *OH for the WOR pathway). This work presents a high-performance photocatalytic system and delivers atomic-scale insights into the sustainable solar-driven H 2 O 2 synthesis process.

✓ 已验证 DOI 高影响因子
查看原文 查看 PubMed
已复制

文献关联基于可获得的产品、CAS、DOI 及引用记录。收录不代表作者或出版方对阿拉丁产品的背书,请以原始文献为准。